R.J. Phillpotts

2.1k total citations
68 papers, 1.6k citations indexed

About

R.J. Phillpotts is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, R.J. Phillpotts has authored 68 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 28 papers in Infectious Diseases and 26 papers in Public Health, Environmental and Occupational Health. Recurrent topics in R.J. Phillpotts's work include Mosquito-borne diseases and control (24 papers), Viral Infections and Vectors (15 papers) and Herpesvirus Infections and Treatments (10 papers). R.J. Phillpotts is often cited by papers focused on Mosquito-borne diseases and control (24 papers), Viral Infections and Vectors (15 papers) and Herpesvirus Infections and Treatments (10 papers). R.J. Phillpotts collaborates with scholars based in United Kingdom, United States and Canada. R.J. Phillpotts's co-authors include John G. Wallace, D. A. J. Tyrrell, Theoderic Brooks, Alice M. Bennett, Stuart D. Perkins, G.M. Scott, Paul G. Higgins, J. S. Porterfield, John Stephenson and Lyn M. O’Brien and has published in prestigious journals such as The Lancet, Advanced Drug Delivery Reviews and Gut.

In The Last Decade

R.J. Phillpotts

68 papers receiving 1.5k citations

Peers

R.J. Phillpotts
David A. Lennette United States
Yuji Kono Japan
John M. Crawford United States
Kenneth F. Soike United States
Jill K. Hacker United States
M Bray United States
William D. Pratt United States
David A. Lennette United States
R.J. Phillpotts
Citations per year, relative to R.J. Phillpotts R.J. Phillpotts (= 1×) peers David A. Lennette

Countries citing papers authored by R.J. Phillpotts

Since Specialization
Citations

This map shows the geographic impact of R.J. Phillpotts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.J. Phillpotts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.J. Phillpotts more than expected).

Fields of papers citing papers by R.J. Phillpotts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.J. Phillpotts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.J. Phillpotts. The network helps show where R.J. Phillpotts may publish in the future.

Co-authorship network of co-authors of R.J. Phillpotts

This figure shows the co-authorship network connecting the top 25 collaborators of R.J. Phillpotts. A scholar is included among the top collaborators of R.J. Phillpotts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.J. Phillpotts. R.J. Phillpotts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Brien, Lyn M., Sarah A. Goodchild, R.J. Phillpotts, & Stuart D. Perkins. (2012). A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge. Virology. 426(2). 100–105. 17 indexed citations
2.
Hu, Weigang, Amanda Phelps, Lyn M. O’Brien, et al.. (2010). A recombinant humanized monoclonal antibody completely protects mice against lethal challenge with Venezuelan equine encephalitis virus. Vaccine. 28(34). 5558–5564. 22 indexed citations
3.
Perkins, Stuart D., Amanda Williams, Lyn M. O’Brien, Thomas R. Laws, & R.J. Phillpotts. (2008). CpG Used as an Adjuvant for an Adenovirus-Based Venezuelan Equine Encephalitis Virus Vaccine Increases the Immune Response to the Vector, But Not to the Transgene Product. Viral Immunology. 21(4). 451–458. 10 indexed citations
5.
Perkins, Stuart D., Helen C. Flick-Smith, Helen S. Garmory, et al.. (2005). Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax. PubMed. 3(1). 3–3. 8 indexed citations
6.
Perkins, Stuart D., M. Gill Hartley, Roman A. Lukaszewski, et al.. (2004). VP22 enhances antibody responses from DNA vaccines but not by intercellular spread. Vaccine. 23(16). 1931–1940. 23 indexed citations
7.
Phillpotts, R.J., Linda D. Jones, Roman A. Lukaszewski, Charles H. Lawrie, & Theoderic Brooks. (2003). Antibody and Interleukin-12 Treatment in Murine Models of Encephalitogenic Flavivirus (St. Louis Encephalitis, Tick-Borne Encephalitis) and Alphavirus (Venezuelan Equine Encephalitis) Infection. Journal of Interferon & Cytokine Research. 23(1). 47–50. 8 indexed citations
8.
Jones, Linda D., Alice M. Bennett, S. R. Moss, Ernest A. Gould, & R.J. Phillpotts. (2003). Cytotoxic T-cell activity is not detectable in Venezuelan equine encephalitis virus-infected mice. Virus Research. 91(2). 255–259. 14 indexed citations
9.
10.
Elvin, Stephen J., Alice M. Bennett, & R.J. Phillpotts. (2002). Role for mucosal immune responses and cell‐mediated immune functions in protection from airborne challenge with Venezuelan equine encephalitis virus*. Journal of Medical Virology. 67(3). 384–393. 19 indexed citations
11.
Bennett, Alice M., et al.. (1999). Recombinant Vaccinia Viruses Protect Against Clostridium perfringens α-Toxin. Viral Immunology. 12(2). 97–105. 21 indexed citations
12.
Brooks, Theoderic & R.J. Phillpotts. (1999). Interferon-α protects mice against lethal infection with St Louis encephalitis virus delivered by the aerosol and subcutaneous routes. Antiviral Research. 41(1). 57–64. 36 indexed citations
13.
Bennett, Alice M., et al.. (1998). Improved Protection against Venezuelan Equine Encephalitis by Genetic Engineering of a Recombinant Vaccinia Virus. Viral Immunology. 11(3). 109–117. 16 indexed citations
14.
Phillpotts, R.J., et al.. (1997). Production of Virus-Specific Antisera Using Synthetic Peptides Corresponding to Sequences in the Yellow Fever E Protein: Brief Report. Viral Immunology. 10(1). 11–14. 3 indexed citations
15.
Ertürk, Murat, R. Jennings, R.J. Phillpotts, & C. W. Potter. (1991). Biochemical characterization of herpes simplex virus type-1-immunostimulating complexes (ISCOMs): a multi-glycoprotein structure. Vaccine. 9(9). 668–674. 16 indexed citations
16.
Ertürk, Murat, R.J. Phillpotts, M.J. Welch, & R. Jennings. (1991). Efficacy of HSV-1 ISCOM vaccine in the guinea-pig model of HSV-2 infection. Vaccine. 9(10). 728–734. 25 indexed citations
17.
Alpar, Oya, et al.. (1990). Preliminary studies on infection by attenuated Salmonella in guinea pig and on expression on herpes simplex virus. Research in Microbiology. 141(7-8). 873–877. 9 indexed citations
18.
Welch, M.J., et al.. (1988). Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs. FEMS Microbiology Letters. 47(3). 157–162. 3 indexed citations
19.
McBride, B.W., et al.. (1988). Mucosal antibody response to vaginal infection with herpes simplex virus in pre-vaccinated guinea-pigs. Vaccine. 6(5). 414–418. 15 indexed citations
20.
Phillpotts, R.J., et al.. (1984). Intranasal Lymphoblastoid Interferon ("Well fer on") Prophylaxis Against Rhinovirus and Influenza Virus in Volunteers. Journal of Interferon Research. 4(4). 535–541. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026